Select Medical (NYSE:SEM) Price Target Lowered to $21.00 at UBS Group

Select Medical (NYSE:SEM) had its price objective lowered by equities researchers at UBS Group from $40.00 to $21.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a “neutral” rating on the health services provider’s stock. UBS Group’s price objective indicates a potential upside of 14.13% from the stock’s current price.

A number of other equities analysts have also recently issued reports on the company. StockNews.com cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday, December 30th. Royal Bank of Canada lifted their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $39.50.

Select Medical Stock Down 2.1 %

Shares of SEM opened at $18.40 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 52-week low of $18.02 and a 52-week high of $40.98. The company has a market cap of $2.38 billion, a PE ratio of 8.60, a P/E/G ratio of 0.39 and a beta of 1.43. The business has a fifty day moving average of $26.91 and a 200 day moving average of $32.21.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the firm posted $0.46 EPS. The firm’s revenue was up 5.7% compared to the same quarter last year. On average, sell-side analysts expect that Select Medical will post 1.97 EPS for the current year.

Insider Transactions at Select Medical

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the sale, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Hedge Funds Weigh In On Select Medical

Large investors have recently made changes to their positions in the business. Dimensional Fund Advisors LP raised its stake in Select Medical by 2.2% in the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock valued at $157,728,000 after buying an additional 95,578 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after acquiring an additional 46,880 shares during the period. Principal Financial Group Inc. raised its stake in Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after acquiring an additional 147,032 shares during the last quarter. Point72 Asset Management L.P. grew its stake in Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Select Medical by 1.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock valued at $57,407,000 after purchasing an additional 24,439 shares during the period. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.